Human Molecular Genetics Advance Access originally published online on August 22, 2005
Human Molecular Genetics 2005 14(19):2801-2811; doi:10.1093/hmg/ddi313
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Mdm muscular dystrophy: interactions with calpain 3 and a novel functional role for titin's N2A domain
1The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA and 2Department of Neurology and Pediatrics, Duchenne Muscular Dystrophy Research Center, University of California, Los Angeles, CA 90095, USA
* To whom correspondence should be addressed. Fax: +1 2072886073; Email:gac{at}jax.org
Received June 30, 2005; Accepted August 10, 2005
Human tibial muscular dystrophy and limb-girdle muscular dystrophy 2J are caused by mutations in the giant sarcomeric protein titin (TTN) adjacent to a binding site for the muscle-specific protease calpain 3 (CAPN3). Muscular dystrophy with myositis (mdm) is a recessive mouse mutation with severe and progressive muscular degeneration caused by a deletion in the N2A domain of titin (TTN-N2A
83), disrupting a putative binding site for CAPN3. To determine whether the muscular dystrophy in mutant mdm mice is caused by misregulation of CAPN3 activity, genetic crosses with CAPN3 overexpressing transgenic (C3Tg) and CAPN3 knockout (C3KO) mice were generated. Here, we report that overexpression of CAPN3 exacerbates the mdm disease, leading to a shorter life span and more severe muscular dystrophy. However, in a direct genetic test of CAPN3's role as a mediator of mdm pathology, C3KO;mdm double mutant mice showed no change in the progression or severity of disease indicating that aberrant CAPN3 activity is not a primary mechanism in this disease. To determine whether we could detect a functional deficit in titin in a non-disease state, we examined the treadmill locomotion of heterozygous +/mdm mice and detected a significant increase in stride time with a concomitant increase in stance time. Interestingly, these altered gait parameters were completely corrected by CAPN3 overexpression in transgenic C3Tg;+/mdm mice, supporting a CAPN3-dependent role for the N2A domain of TTN in the dynamics of muscle contraction.
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A. Kontrogianni-Konstantopoulos, M. A. Ackermann, A. L. Bowman, S. V. Yap, and R. J. Bloch Muscle Giants: Molecular Scaffolds in Sarcomerogenesis Physiol Rev, October 1, 2009; 89(4): 1217 - 1267. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Murphy and G. D. Lamb Endogenous Calpain-3 Activation Is Primarily Governed by Small Increases in Resting Cytoplasmic [Ca2+] and Is Not Dependent on Stretch J. Biol. Chem., March 20, 2009; 284(12): 7811 - 7819. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Lopez, P. S. Pardo, G. A. Cox, and A. M. Boriek Early mechanical dysfunction of the diaphragm in the muscular dystrophy with myositis (Ttnmdm) model Am J Physiol Cell Physiol, November 1, 2008; 295(5): C1092 - C1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Hayashi, Y. Ono, N. Doi, F. Kitamura, M. Tagami, R. Mineki, T. Arai, H. Taguchi, M. Yanagida, S. Hirner, et al. Multiple Molecular Interactions Implicate the Connectin/Titin N2A Region as a Modulating Scaffold for p94/Calpain 3 Activity in Skeletal Muscle J. Biol. Chem., May 23, 2008; 283(21): 14801 - 14814. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Murphy, C. A. Goodman, M. J. McKenna, J. Bennie, M. Leikis, and G. D. Lamb Calpain-3 is autolyzed and hence activated in human skeletal muscle 24 h following a single bout of eccentric exercise J Appl Physiol, September 1, 2007; 103(3): 926 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ono, F. Torii, K. Ojima, N. Doi, K. Yoshioka, Y. Kawabata, D. Labeit, S. Labeit, K. Suzuki, K. Abe, et al. Suppressed Disassembly of Autolyzing p94/CAPN3 by N2A Connectin/Titin in a Genetic Reporter System J. Biol. Chem., July 7, 2006; 281(27): 18519 - 18531. [Abstract] [Full Text] [PDF] |
||||



